Key result
During November 2021–December 2022, nine cases of paralytic polio caused by wild poliovirus type 1 were detected in southeastern Africa, prompting multiple rounds of supplementary immunization activities.
Why the study?
Following confirmation of imported WPV1 cases in southeastern Africa, this report summarizes progress in the outbreak response.
Observational (n=9)
An outbreak of wild poliovirus type 1 in southeastern Africa resulted in 9 cases, prompting a multi-country response to enhance surveillance and immunization, though gaps remain.
Alerts clinicians to possible wild poliovirus resurgence in Africa; leaves open whether eradication strategies require revision.
Since the Global Polio Eradication Initiative (GPEI) began in 1988, the number of wild poliovirus (WPV) cases has declined by >99.99%. Five of the six World Health Organization (WHO) regions have been certified free of indigenous WPV, and WPV serotypes 2 and 3 have been declared eradicated globally (1). WPV type 1 (WPV1) remains endemic only in Afghanistan and Pakistan (2,3). Before the outbreak described in this report, WPV1 had not been detected in southeastern Africa since the 1990s, and on August 25, 2020, the WHO African Region was certified free of indigenous WPV (4). On February 16, 2022, WPV1 infection was confirmed in one child living in Malawi, with onset of paralysis on November 19, 2021. Genomic sequence analysis of the isolated poliovirus indicated that it originated in Pakistan (5). Cases were subsequently identified in Mozambique. This report summarizes progress in the outbreak response since the initial report (5). During November 2021-December 2022, nine children and adolescents with paralytic polio caused by WPV1 were identified in southeastern Africa: one in Malawi and eight in Mozambique. Malawi, Mozambique, and three neighboring countries at high risk for WPV1 importation (Tanzania, Zambia, and Zimbabwe) responded by increasing surveillance and organizing up to six rounds of national and subnational polio supplementary immunization activities (SIAs).* Although no cases of paralytic WPV1 infection have been reported in Malawi since November 2021 or in Mozambique since August 2022, undetected transmission might be ongoing because of poliovirus surveillance gaps and testing delays. Efforts to further enhance poliovirus surveillance sensitivity, improve SIA quality, and strengthen routine immunization are needed to ensure that WPV1 transmission has been interrupted within 12 months of the first case, thereby preserving the WHO African Region's WPV-free status.
No takes yet. Share an insight, caveat, or question.
Davlantes et al. (2023) conducted an observational in Paralytic polio caused by Wild Poliovirus Type 1 (WPV1) (n=9). Wild Poliovirus Type 1 Outbreak and Public Health Response was evaluated on Detection of WPV1 cases and surveillance performance. During November 2021–December 2022, nine cases of paralytic polio caused by wild poliovirus type 1 were detected in southeastern Africa, prompting multiple rounds of supplementary immunization activities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: